Want to join the conversation?
$CPGX reported that OpEx, excluding the impact of trackers, increased by $17.6MM, mainly due to higher D&A, increased employee and administrative costs, and higher outside service costs. Equity earnings increased by $0.5MM in the quarter.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.